DMAA

Drugs Made In America Acquisition Corp. Stock Price

NasdaqGM:DMAA Community·US$357.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DMAA Share Price Performance

US$10.60
0.48 (4.74%)
US$10.60
0.48 (4.74%)
Price US$10.60

DMAA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with questionable track record.

4 Risks
1 Reward

Drugs Made In America Acquisition Corp. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

-US$6.7m

Other Expenses

US$6.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.20
0%
0%
-1.4%
View Full Analysis

About DMAA

Founded
2024
Employees
n/a
CEO
Roger Bendelac
Website
n/a

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Recent DMAA News & Updates

Recent updates

No updates